Nanosphere Coated with Lactosyl-Polystyrene Polymer as a Targeting Carrier to Hepatocytes

REFERENCES

• Bazile, D., Prud’Homme, C., Bassoullet, M. T., Marlard, M., Spenlehauer, G., and Veillard, M. 1995. Stealth Me. PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. J. Pharm. Sci. 84:493–498.
   PubMed Web of Science ®Google Scholar
• Bazile, D. V., Ropert, C., Huve, P., Verrecchia, T., Marlard, M., Frydman, A., Veillard, M., and Spenlehauer, G. 1992. Body distribution of fully biodegradable [14C]-poly(lacticacid)nanoparticlescoatedwithalbuminafterparenteral administration to rats. Biomaterials 13:1093–1102.
   PubMed Web of Science ®Google Scholar
• Chiannilkulchai,N.,Ammoury,N.,Caillou, B., Devissaquet,J. P.,andCouvreur, P. 1990. Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing mice. Cancer Chemother. Pharmacol. 26:122–126.
   PubMed Web of Science ®Google Scholar
• Coffin, M. D., and McGinity, J. W. 1992. Biodegradabl epseudolatexs: The chemical stability of poly (d, L-lactide) and poly (-caprolactone) nanoparticle s in aqueous media. Pharm. Res. 9:200–205.
   PubMed Web of Science ®Google Scholar
• Couvreur, P., Fattal, E., Alphandary, H., Puisieux, F., and Andremont, A. 1992. Intracellular targeting of antibiotics by means of biodegradabl e nanoparticles. J. Control Release 19:259–268.
   Google Scholar
• Couvreur, P., Kante, B., Grislain, L., Roland, M., andSpeiser, P. 1982. Toxicity of polyalkylcyanoacrylat e nanoparticles. II: Doxorubicin loaded nanoparticles. J. Pharm. Sci. 71:790–792.
   PubMed Web of Science ®Google Scholar
• De Keyser, J. L., Poupaert, J. H., and Dumont, P. 1991. Poly (diethyl methyli-denemalonate) nanoparticles as a potential drug carrier: Preparation, distribution and elimination after intravenous and peroral administration to mice. J. Pharm. Sci. 80:67–70.
   PubMed Web of Science ®Google Scholar
• Douglas, S. J., Davis, S. S., and Illum L. 1986. Biodistribution of poly (butyl 2-cyanoacrylate) nanoparticles in rabbits. Int. J. Pharm. 34:145–152.
   Web of Science ®Google Scholar
• Goto, M., Yura, H., Chang, C. W., Kobayashi, A., Shinoda, T, Maeda, A., Kojima, S., Kobayashi, K., and Akaike, T. 1994. Lactose-carrying polystyrene as a drug carrier: investigation of body distributions to parenchyma l liver cells using 125I-labelled lactose-carrying polystyrene. J. Control Release 28:223–233.
   Web of Science ®Google Scholar
• Hanada, T, Eguchi, Y., and Miyajima, K. 1994. Effects of cholesterol and cholesteryl oleate on lipolysis and liver uptake of triglyceride/phosphatidylcholine emulsion in rats. Pharm. Res. 11:1283–1287.
   PubMed Web of Science ®Google Scholar
• Illum, L., Davis, S. S., Muler, R. H., Make, E., and West, P. 1987. The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block-copolymer-poloxamin e 908. Life Sci. 40:367–374.
   PubMed Web of Science ®Google Scholar
• Illum, L., Hunneyball, I. M., and Davis, S. S. 1986. The effect of hydrophilic coating on the uptake of colloidal particles by the liver and by peritoneal macropahrges. Int. J. Pharm. 29:53–65.
   Web of Science ®Google Scholar
• Jeon, S. I., Lee, J. H., Andrade, J. D., and De Gennes, P. G. 1991. Protein surface interactions in the presence of polyethylene oxide) I. Simplified theory. J. Colloid Interface Sci. 142:149–158.
   Web of Science ®Google Scholar
• Kobayashi, K., Sumitomo, H., andIna Y. 1985. Synthesis andfunctions ofpoly-styrene derivatives having pendant oligosaccharides. Polymer J. 17:567–575.
   Web of Science ®Google Scholar
• Lenaerts, V., Nagelkerke, J. F., Van Berkel, T. J. C, Couvreur, P., Grislain, L., Roland, M., and Speiser, P. 1984. In vivo uptake of polyisobutylcyanoacrylat e nanoparticles by rat liver kupffer, endothelial and parencymal cells. J. Pharm. Sci. 73:980–983.
   PubMed Web of Science ®Google Scholar
• Loughrey, H. C, Ferraretto, A., Cannon, A. M., Acerbis, G., Sudati, F., Bottiroli, G., Masserini, M., and Soria, M. R. 1993. Charracterisation of biotinylated liposomes for in vivo targeting applications. Federation of European Biochemical Societies 332:183–188.
   PubMed Web of Science ®Google Scholar
• Nomura, T, Koreeda, N., Yamashita, F., Takakura, Y, and Hashida, M. 1998. Effect of particle size and charge on the distribution of lipid carriers after intratumoral injection into tissue-isolated tumors. Pharm. Res. 15:128–132.
   PubMed Web of Science ®Google Scholar
• Norde, W., and Lyklema, J. 1991. Why proteins prefer interfaces. J. Biomater Sci. PolymerEdn. 2, 3:182–202.
   Google Scholar
• Ogawara, K., Nishikawa, M., Takakura, Y, and Hashida, M. 1998. Pharmacokinetic analysis of hepatic uptake of galactosylated bovine serum albumin in a perfused rat liver. J. Control Release 50:309–317.
   PubMed Web of Science ®Google Scholar
• Oka, J. A., Christensen, M. D., and Weigel, P. H. 1989. Hyperosmolarity inhibits galactosyl receptor-mediated but not fluid phase endocytosis in isolated rat hepatocytes. J. Biol. Chem. 264:12016–12024.
   PubMed Web of Science ®Google Scholar
• Seglen, P. O. 1976. Preparation of isolated rat liver cells. Methods Cell Biol. 13:29–83.
   PubMedGoogle Scholar
• Seijo, B., Fattal, E., Roblot-Treupel, L., and Couvreur, P. 1990. Design of nanoparticles of less then 50 nm diameter: Preparation, characterization and drug loading. Int. J. Pharm. 62:1–7.
   Web of Science ®Google Scholar
• Takino, T, Konishi, K., Takakura, Y, and Hashida, M. 1994. Long circulating emulsion carrier systems for highly lipophilic drugs. Biol. Pharm. Bull. 17:121–125.
   PubMed Web of Science ®Google Scholar
• Waser, P. G., Muler, U., Kreuter, J., Berger, S., Munz, S., Kaiser, E., andPfluger, B. 1987. Localization of colloidal particles (liposome, hexylcyanoacrylate nanoparticles and albumin nanoparticles) by histological and autoradiography in mice. Int. J. Pharm. 39:213–227.
   Web of Science ®Google Scholar